Covered recipient · General Payments record
ROBIN SCOTT DIBIASE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,499.24
- Reported across 159 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,244.38 | 70 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $151.83 | 9 |
| Janssen Biotech, Inc. | $143.81 | 12 |
| Astellas Pharma US Inc | $117.81 | 7 |
| Daiichi Sankyo Inc. | $100.51 | 5 |
| Merck Sharp & Dohme Corporation | $91.11 | 4 |
| PFIZER INC. | $66.20 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $59.50 | 3 |
| Alnylam Pharmaceuticals Inc. | $57.42 | 3 |
| Stemline Therapeutics Inc. | $39.00 | 1 |
| Celgene Corporation | $37.59 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $36.29 | 2 |
| E.R. Squibb & Sons, L.L.C. | $32.17 | 2 |
| ABBVIE INC. | $31.92 | 2 |
| GlaxoSmithKline, LLC. | $29.97 | 1 |
| SOBI, INC | $27.79 | 1 |
| ARRAY BIOPHARMA INC | $24.39 | 1 |
| SpringWorks Therapeutics, Inc. | $21.69 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.68 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.42 | 1 |
| Rigel Pharmaceuticals, Inc. | $20.09 | 2 |
| Mirati Therapeutics, Inc. | $19.57 | 1 |
| AVEO Pharmaceuticals, Inc. | $18.81 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.29 | 1 |
| Apellis Pharmaceuticals, Inc. | $14.65 | 1 |
| Genentech USA, Inc. | $14.13 | 1 |
| EISAI INC. | $13.90 | 1 |
| Lilly USA, LLC | $13.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (70)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.